This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.03% per year. These returns cover a period from January 1, 1988 through July 1, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
UnitedHealth Group, Inc. is the largest health care services company in the world, serving over 50 million individuals in the United States as of 2019 and over 5 million internationally. The company provides a wide range of health care products and services, such as health maintenance organizations (HMOs), point of service plans (POS), preferred provider organizations (PPOs), and managed fee-for-service programs. UnitedHealth has the largest and most diverse membership base within the managed-care organization market, which gives it significant competitive advantages. It also has built its prescription drug business through OptumRx division, with the acquisition of Catamaran in 2015.
The Zacks Analyst Blog Highlights: Molina, WellCare, Humana and UnitedHealth
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Molina, WellCare, Humana and UnitedHealth
How to Survive a Stock Market Sell Off
by Tracey Ryniec
Scared about the recent sell off and unsure what to do? Have a plan.
Obamacare Set to Gain From Mid-Term Polls: 4 HMO Picks
by Swarup Gupta
HMOs, which have expanded their market share in the post-Obamacare era, are expected to gain from this trend.
Play UnitedHealth's Q3 Earnings Beat With These 3 Funds
by Zacks Equity Research
Following UnitedHealth's encouraging earnings results, investing in healthcare mutual funds with a significant holding in the company will be prudent
UnitedHealth Group (UNH) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
In the latest trading session, UnitedHealth Group (UNH) closed at $262.19, marking a -1.17% move from the previous day.
Quiet Friday Session Caps Another Volatile Week in the Markets
by David Borun
Earnings and Geopolitical events contribute to another wild ride
Top-Ranked Healthcare ETFs for Long-Term Investors
by Neena Mishra
Healthcare is now the best-performing sector of 2018. We highlight two top-ranked ETFs suitable for long-term investors.
Stock Market News For Oct 18, 2018
by Zacks Equity Research
Markets ended mostly lower after a volatile trading session on Wednesday.
Stock Market News For Oct 17, 2018
by Zacks Equity Research
Wall Street rebounded on Tuesday as stocks surged across the board due to strong third-quarter 2018 earnings results and impressive economic data.
5 Stocks Moving After Tuesday's Pre-Market Earnings
by Ryan McQueeney
U.S. stocks were sharply higher through early afternoon trading Tuesday as investors looked for an entry point following the extension of last week's losses yesterday. The catalyst for today's buying appears to be a handful of impressive pre-market earnings reports.
This Week's Most Spectacular Earnings Charts
by Tracey Ryniec
It doesn't get much better than these five big cap companies with their outstanding earnings surprise records and great earnings charts.
Q3 Earnings Reports: MSFT, NFLX, GS, MS, UNH, JNJ
by Zacks Equity Research
Q3 Earnings Reports: MSFT, NFLX, GS, MS, UNH, JNJ
Q3 Earnings Results Impress: GS, MS, UNH & More
by Mark Vickery
Q3 earnings reports are hitting the tape fast and furious at this hour. We will take this opportunity to summarize a handful of them.
UnitedHealth's (UNH) Q3 Earnings Beat, 2018 Guidance Raised
by Zacks Equity Research
UnitedHealth's (UNH) Q3 results gained from higher revenues from both its segments and increase in membership.
UnitedHealth Group (UNH) Q3 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
UnitedHealth (UNH) delivered earnings and revenue surprises of 3.33% and 0.76%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?
Will Optum Aid UnitedHealth Group's (UNH) Q3 Earnings?
by Zacks Equity Research
Revenue and earnings gains across all the Optum's subsegments should aid UnitedHealth's Q3 earnings.
Friday Bounce Ends a Volatile Week for Stocks
by David Borun
Interest rates fears fuel the biggest weekly decline in 7 months
UnitedHealth Group (UNH) Gains But Lags Market: What You Should Know
by Zacks Equity Research
In the latest trading session, UnitedHealth Group (UNH) closed at $259.41, marking a +0.89% move from the previous day.
Should You Buy UnitedHealth Group (UNH) Ahead of Earnings?
by Zacks Equity Research
UnitedHealth Group (UNH) is seeing favorable earnings estimate revision activity as of late, which is generally a precursor to an earnings beat.
Will UnitedHealth's (UNH) Revenue Growth Aid Q3 Earnings?
by Zacks Equity Research
Revenue growth at the company's Optum and United Healthcare segments should drive earnings in Q3.
UnitedHealth Group (UNH) Q3 Earnings Preview: What to Know Ahead of the Release
by Zacks Equity Research
UnitedHealth (UNH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
WellCare Health, agilon health to Provide Value-Based Care
by Zacks Equity Research
WellCare Health (WCG) purchases agilon health to provide enriched patient care in Texas.
Stocks Take a Breather as Rates Rise
by David Borun
An increase in rates at the back end of the curve spooks investors, but the fundamanentals remain strong.
Molina Healthcare Sells MMS Unit to Streamline Business
by Zacks Equity Research
Molina Healthcare (MOH) sells its Medicaid Solutions unit to focus on core operations.
MEDNAX Buys Radiology Specialists to Expand Business
by Zacks Equity Research
MEDNAX (MD) boosts its radiology business with the acquisition of Radiology Specialists.